Orphazyme A/S, a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases announces that it has completed...
Read more
Cryoport, Inc and EVERSANA have announced a strategic alliance to further create a fully integrated regenerative medicine supply chain solution....
Read more
Hilleman Laboratories, a global research and development organization focused on delivering high-impact and affordable vaccines, announced that it has entered...
Read more
IBM and Walmart announced that the companies have been selected by the US FDA to be included in a program...
Read more
Boehringer Ingelheim and Gubra announce a second collaboration and license agreement for the development of novel poly-agonist peptides to treat...
Read more
Lantheus Holdings has collaborated with NanoMab Technology to provide a novel biomarker for clinical development and management of immuno-oncology therapies....
Read more
AstraZeneca and Merck presented full results from the Phase 3 SOLO3 trial which evaluated LYNPARZA, compared to chemotherapy, for the...
Read more
ProtoKinetix, announced reaching the midpoint of a Phase-1 first-in-human clinical trial of AAGP PKX-001 treated islet cells used in conjunction...
Read more
nference, a leader in knowledge synthesis software solutions for the life sciences industry announced a multi-year alliance with Janssen Research...
Read more
AstraZeneca has announced Calquence (acalabrutinib) reached both its primary and secondary endpoints in chronic lymphocytic leukaemia (CLL). In preliminary analysis...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
